Sulopenem is an investigational drug.
There have been 7 clinical trials for Sulopenem.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 18th 2018.
The most common disease conditions in clinical trials are Communicable Diseases, Infections, and Infection. The leading clinical trial sponsors are Iterum Therapeutics, International Limited, Iterum Therapeutics, US Limited, and Pfizer.
There are one hundred and thirty-two US patents protecting this investigational drug and seven hundred and thirty-four international patents.